Cord blood: a promising source of allogeneic natural killer cells for immunotherapy
Authors:
- 1 January 2015
- journal article
- editorial
- Published by Elsevier in Cytotherapy
- Vol. 17 (1) , 1-2
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Differential activation of cord blood and peripheral blood natural killer cells by cytokinesCytotherapy, 2014
- Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion proteinBlood, 2014
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer CellsPLOS ONE, 2012
- Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell educationBlood, 2010
- The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cellsBritish Journal of Haematology, 2009
- A Programmed Switch from IL-15- to IL-2-Dependent Activation in Human NK CellsThe Journal of Immunology, 2009
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell TherapyCancer Research, 2009
- Interleukin‐21 activates human natural killer cells and modulates their surface receptor expressionImmunology, 2008